PharmaCyte Biotech, Inc.
Developing encapsulated cell therapies for targeted cancer and diabetes treatments.
PMCB | NDAQ
Overview
Corporate Details
- ISIN(s):
- US71715X2036
- LEI:
- Country:
- United States of America
- Address:
- 3960 HOWARD HUGHES PARKWAY, 89169 LAS VEGAS
- Website:
- https://pharmacyte.com/
- Sector:
- Mining and quarrying
- Industry:
- Mining of non-ferrous metal ores
Description
PharmaCyte Biotech, Inc. is a clinical-stage biotechnology company focused on developing and commercializing cellular therapies for cancer and diabetes. The company's core technology is its proprietary live-cell encapsulation platform, 'Cell-in-a-Box®'. This system is designed to encapsulate genetically engineered human cells that can be placed in the body to produce and deliver therapeutic agents. For its cancer therapy, the encapsulated cells convert an inactive chemotherapy prodrug into its active form directly at the tumor site, aiming to improve efficacy and reduce side effects. The company's primary focus is on developing treatments for pancreatic and other solid cancerous tumors.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PharmaCyte Biotech, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PharmaCyte Biotech, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PharmaCyte Biotech, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
